Journal article icon

Journal article

Clinical pharmacokinetics of mefloquine.

Abstract:

Mefloquine, a quinoline-methanol antimalarial, is effective single dose therapy for all species of malaria infecting humans, including multi-drug-resistant Plasmodium falciparum. It is used both in prophylaxis and treatment. Mefloquine is available either as the hydrochloride salt alone, or in a combined preparation with sulfadoxine and pyrimethamine. There is no parenteral formulation. Several assay methodologies have been developed, but high performance liquid chromatography has been the mo...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Karbwang, J More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Thailand/Laos MOP
Journal:
Clinical pharmacokinetics
Volume:
19
Issue:
4
Pages:
264-279
Publication date:
1990-10-05
DOI:
ISSN:
0312-5963
URN:
uuid:744d8161-3a9a-4003-8b8d-37193e211ae7
Source identifiers:
43473
Local pid:
pubs:43473

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP